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TRANSLATIONAL IMMUNOLOGY IN KIDNEY DISEASE, ISN NEXUS SYMPOSIUM 2016correlated with the reduction of tubular injury (PAS, Kim-1), renal
inﬂammation (Macrophages, T cells, IL-6, TNF-, RANTES and
CCL2) as well as renal ﬁbrosis (SMA, Col1a1, Masson Trichrome).
Conclusions: Therefore, we conclude that BHB ameliorates acute
oxalate nephropathy, as well as delays progressive renal failure by
inhibiting NLRP3-mediated inﬂammation. Our ﬁndings suggest
that ketogenic diets or -hydroxybutyrate formulations can be used
therapeutically for the treatment of primary hyperoxaluria related
kidney stone disease.
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Introduction: A newly-described 1st-line immune defence mecha-
nisms of neutrophils is the extrusion of DNA, called neutrophil
extracellular traps (NETs). Known non-infectious triggers of
NETosis are phorbol 12-myristate 13-acetate (PMA), IL-8 and im-
mune complexes (ICx). In vitro, PMA and IL-8 are strong inducers
of NET release and generally involves all cultured neutrophils.
However, ICx induce much lower numbers of neutrophils to release
NETs. As such, the in vitro quantiﬁcation of NETs is challenging
with current methodologies (i.e. Picogreen or immunoﬂuorescence).
In order to investigate the role of NET release in ICx-mediated
autoimmune diseases, we developed a novel method for automated
and highly sensitive measurement of NETs, applicable in a
high-throughput system.
Methods: Healthy neutrophils are isolated from fresh blood and
labelled with the membrane staining PKH26, which serves as a cell
marker. Neutrophils are stimulated for 4 hours with various con-
centrations of heat-aggregated human IgG ICx. After 33/4 hours,
Sytox green is added to stain extracellular DNA. Sytox green is
incubated for 15 minutes, after which the cells are ﬁxed with 4%
PFA. Within 24 hours, the 96-well plate is automatically imaged
with the BD Pathway 855. The ratio of the sum of Sytox green area
and average PKH area is calculated, representing the amount of
NETs in each sample. A higher ratio indicates a higher amount of
extracellular DNA present.
Results: Immunoﬂuorescence analysis of ICx-stimulated neutro-
phils revealed colocalization of extracellular DNA staining with
citrullinated histon3 and neutrophil elastase, conﬁrming the release
of NETs. The amount of NET release was quantiﬁed with ImageJ
software, by determining the ratio between positive Sytox green
area and the positive PKH26 area, of which we found that it
accurately represents the amount of cells imaged. Sensitivity is
highly increased since 11% of the total area per well is imaged and
a z-stacking system is used to image NETs superimposed on neu-
trophils. We further characterized NET release upon stimulation
with these ICx. When pre-treated with diphenyleneiodonium (DPI),
used to block production of reactive oxygen species (ROS), NET
release upon ICx stimulation was not affected.Kidney International Reports (2016) 1, S1–S22Conclusions:We developed a novel assay that is highly sensitive to
detect and quantify in vitro NET release. NET release triggered by
human ICx was detected reliably and appeared to be a ROS-inde-
pendent process. This assay will allow high-throughput and highly
sensitive analysis of NET release in ICx-mediated autoimmune
diseases (e.g. systemic lupus erythematosus, rheumafactor positive
rheumatoid arthritis or cryoglobulinemic vasculitis).
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Introduction: IL-33 is an important immune regulator which can
promote Th2 immune response-dependent immunity, inﬂammation,
and tissue repair in several important immune-mediated disorders.
In the current study, we sought to determine whether IL-33 is an
important regulator in renal ischaemic/reperfusion injury (IRI).
Methods: Bilateral renal ischemia was imposed in C57BL/6 mice
under isoﬂuorane anesthesia. IL-33 was given by 5 consecutive
daily injections starting at day 5 before IRI operation. Adoptive
transfer of type 2 innate lymphoid cells into mice with IRI was used
to assess their in vivo functions.
Results: Treating IRI mice with IL-33 signiﬁcantly improved renal
function and reduced renal injury. The possible mechanisms un-
derlying the protective effect of IL-33 were examined. Firstly, IL-33
increased the levels of IL-4, IL-5 and IL-13 in serum and kidney and
promoted induction of alternatively activated (M2) macrophages in
kidney. Moreover, the number of NK cells and neutrophils was
signiﬁcantly reduced in IRI mice treated with IL-33. A novel
ﬁnding of this study was that IL-33 increased the frequency of type
2 innate lymphoid cells (ILC2) and regulatory T cells (Tregs) in
kidney. However, adoptive transfer of ILC2 not only reduced renal
functional and histological injury in IRI mice but also induced M2
macrophages in kidney.
Conclusions: In conclusion, our data identify a mechanism
whereby IL-33 eliciting ILC2 and Tregs regulate macrophage
phenotype in kidney and prevent renal IRI.
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Introduction:We have recently characterized Foxp3+ regulatory T
cells, co-expressing the Th17 characteristic transcription factor
ROR t, as an independent and bi-functional T cell lineage (biTregs).
biTregs secrete both, anti-inﬂammatory (IL-10, IL-35), but also pro-
inﬂammatory (IL-17) cytokines. Studies in a model of acute cres-
centic glomerulonephritis have suggested that pro- inﬂammatory
biTreg functions are largely mediated by ROR t. This is of high
clinical relevance, since multiple ROR t blocking agents areS11
TRANSLATIONAL IMMUNOLOGY IN KIDNEY DISEASE, ISN NEXUS SYMPOSIUM 2016currently under development. We thus studied the therapeutic
potential of interference with ROR t activation in biTregs using the
model of pristane induced chronic systemic lupus erythematosus
(SLE).
Methods: Foxp3Cre x RORCﬂ/ﬂ mice with selective deﬁciency of
ROR t in biTregs were generated (biTregROR-). SLE was induced
by i.p. injection of pristane oil. Systemic auto-immunity, renal
immune responses and tissue injury were studied between 2 and
8 months after disease induction.
Results: Time course analyses showed increasing inﬁltration of
biTregs into kidneys of pristane injected mice with a maximum at
around 5 months. In order to study the functional role of ROR t in
biTregs, the course of SLE was analyzed in biTregROR- mice.
Assessment of renal histology at 8 months showed severe prolif-
erative glomerulonephritis in pristane injected wild type mice.
Histological injury and glomerular cell proliferation in the biTre-
gROR- group, in contrast, was signiﬁcantly ameliorated. In line,
renal inﬂammatory leukocyte inﬁltration, blood urea nitrogen
levels and albuminuria were also reduced by knockout of ROR t in
biTregs. As one possible explanation for the improved outcome, we
found that biTregs from wild type mice produced pro-inﬂammatory
IL-17 at all observed time points, while biTregs from biTregROR-
mice did not. Furthermore, systemic and organ speciﬁc immune
responses were strikingly skewed towards protective Th2 immu-
nity in biTregROR- mice. Next, effects of biTreg expressed ROR t
on development of humoral auto-immunity were studied. Analyses,
however, showed unaltered serum anti-U1-RNP auto-antibody
levels of all isotypes. Likewise, renal IgG and complement C3
deposition remained unchanged. This indicates that ROR t activa-
tion in biTregs directs renal injury by cellular effectors but does
not play a major role for generation of humoral auto-immunity.
Conclusions: In summary, our data thus provide ﬁrst evidence for
presence and functional importance of biTregs in SLE. Importantly,
biTreg expressed ROR t was identiﬁed as factor promoting devel-
opment of renal injury via induction of IL-17 secretion and sup-
pression of Th2 immunity. Our data therefore favor ROR t directed
interventions as innovative new therapeutic option for lupus
nephritis.
P25
GENERATION, PHENOTYPE AND
FUNCTION OF EX VIVO INDUCED
HUMAN REGULATORY T CELLS
Fierro, A1, Candia, E2, Covian, C3, Rodriguez, F3,
Wainstein, N3, Morales, J2, Mosso, C4, Rosemblatt, M5
1Clinica Las Condes, Santiago, Chile; 2Clinica Las Condes, Unidad de
Trasplantes, Santiago, Chile; 3Universidad Andres Bello, Facultad de Cien-
cias Biologicas, Santiago, Chile; 4Clinica Las Condes, Departamento de
Hemaooncologia, Santiago, Chile; 5Universidad de Chile- Fundacion Cien-
cia & Vida- Universidad Andres Bello, Facultad de Ciencias, Santiago, Chile
Introduction: Adoptive transfer of regulatory T cells (Tregs) rep-
resents a promising strategy to modulate autoimmune diseases
including renal diseases, as well as bone marrow and organ trans-
plantation. Studies performed in mice and humans have shown the
feasibility of generating Treg ex vivo from naive T cells (nT) in the
presence of IL-2 / TGF , all-trans retinoic acid (atRA) and rapamycin
(RAPA). This study reports the expansion, differential expression
of homing receptors; methylation of the conserved non-coding
sequence 2 (CNCS2) of foxp3, and function of polyclonal human
Treg induced from nT in short-term cultures.
Methods: nT were isolated from healthy volunteers by negative
selection, polyclonally stimulated with anti-CD3 plus anti-CD28S12antibodies and cultured in the presence of IL-2 and TGF for 5 days.
RAPA and/or atRA were added at different concentrations. The
induced Tregs were characterized by ﬂow cytometry and sup-
pression assays in vitro, methylation of the CNCS2 was evaluated
by bisulphite conversion and pyro-sequencing.
Results: Results show that atRA improves while Rapa reduces the
generation of Treg in this short-term setting. atRA enhanced the
expression of 7, while the expression of CXCR4 is increased by
RAPA. Functional assessment showed that Treg generated in the
presence of RAPA had the highest suppressor effect. Methylation
assays showed that atRA and RAPA did not lower the high
methylation of the induced Treg, however polyclonal re-stimula-
tion in the presence of atRA and RAPA was related to diminished
methylation of the CNCS2.
Conclusions: These results show that the presence of atRA and
RAPA contributes to the generation and function of induced Treg,
providing each a differential expression of homing receptors.
Repeated polyclonal stimulation in the presence of atRA and RAPA
may contribute to decrease the methylation of the critical CNCS2.
These results open the possibility of modulating the phenotype and
function of Treg generated ex vivo, thus manufacturing Treg with
diverse characteristics depending on the context and clinical
purpose.
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Introduction: Approximately 5% of children with MCD and even
more number of MCD in adults are steroid resistant. Of those pa-
tients who are found to have FSGS, about 15% will respond to
conventional oral steroid therapy, remaining 85% of patients are
steroid resistant and are at substantial risk to progress to ESRD.
Thus, present study was undertaken to know underlying different
etiologies with special emphasis to calcineurin inhibitors as a
treatment options for frequent relapsing and steroid resistant
nephrotic syndrome in both children and adults.
Methods: The present study was an observational analysis of 30
patients with frequently relapsing or steroid resistant nephrotic
syndrome treated with calcineurin inhibitors in addition to low
dose steroid therapy presenting to the IKDRC-ITS, during the
period from September 2012 to March 2015. Inclusion criteria:
FRNS & SRNS were deﬁned by KDIGO guidelines. Only patients
undergone renal biopsy to deﬁne morphology were included. FRNS
or SRNS patients treated with calcineurin inhibitors (Cyclosporine
or Tacrolimus) at least for 6 months to deﬁne response were
included. Exclusion criteria: 1. Children < 1 year of age (to exclude
congenital nephrotic syndrome). 2. Patients with systemic disease
like lupus, diabetes and other causes of secondary nephrotic syn-
drome were excluded. As per recommendations of KDIGO, patients
with FRNS & SRNS were treated with cyclosporine or tacrolimus
for a minimum of 6 month period.
Results: Overall FSGS was the most common etiology in 13 (44%)
patients followed by IgM nephropathy in 8 (26%) patients, MePGN
in 5 (17%) and MCD in 4 (13%) patients. After 3 months of
treatment with CNI in majority of patients, proteinuria reduced to
subnephrotic range and Sr. albumin increased to >2.5 gm/dl. Renal
function remained stable during CNI treatment. OverallKidney International Reports (2016) 1, S1–S22
